dr Marta Kędziora

dr Marta Kędziora

+48 12 6623243
pokój 116
Zakład Neurochemii

Dokonania naukowe

  • Publikacje

Mimicking the Human Articular Joint with In Vitro Model of Neurons-Synoviocytes Co-Culture

Autorzy: Jakub Chwastek, Marta Kędziora, Małgorzata Borczyk, Michał Korostyński, Katarzyna Starowicz

DOI: 10.15283/ijsc23043
Date: 2024-02-28

Network analysis of monoamines involved in anxiety-like behavior in a rat model of osteoarthritis

Autorzy: Jakub Mlost, Magdalena Białoń, Marta Kędziora, Agnieszka Wąsik, Żaneta Michalec, Katarzyna Starowicz

DOI: 10.1007/s43440-023-00562-5
Date: 2024-02-01

Inhibition of anandamide breakdown reduces pain and restores LTP and monoamine levels in the rat hippocampus via the CB1 receptor following osteoarthritis

Autorzy: Marta Kędziora, PhD, Marta Kędziora, Serena Boccella, Ida Marabese, Jakub Mlost, Rosmara Infantino, Sabatino Maione, Katarzyna Starowicz

DOI: 10.1016/j.neuropharm.2022.109304
Date: 2023-01-01

Inflammation-Driven Secretion Potential Is Upregulated in Osteoarthritic Fibroblast-Like Synoviocytes

Autorzy: Jakub Chwastek, Marta Kędziora, Małgorzata Borczyk, Michał Korostyński, Katarzyna Starowicz

DOI: 10.3390/ijms231911817
Date: 2022-10-05

Antinociceptive and chondroprotective effects of prolonged β-caryophyllene treatment in the animal model of osteoarthritis: Focus on tolerance development

Autorzy:

DOI: 10.1016/j.neuropharm.2021.108908
Date: 2022-02-01

Computational Approach Reveals Pronociceptive Potential of Cannabidiol in Osteoarthritis: Role of Transient Receptor Potential Channels

Autorzy:

DOI: 10.3390/ph14100964
Date: 2021-09-24

Cannabinoid-based therapy as a future for joint degeneration. Focus on the role of CB2 receptor in the arthritis progression and pain: an updated review

Autorzy: Marta Bryk, Katarzyna Starowicz

DOI: 10.1007/s43440-021-00270-y
Date: 2021-06-28

MESENCHYMAL STEM CELLS AND EXTRACELLULAR VESICLES FOR THE TREATMENT OF PAIN: CURRENT STATUS AND PERSPECTIVES

Autorzy:

DOI: 10.1111/bph.15569
Date: 2021-05-24

Sodium Monoiodoacetate Dose-Dependent Changes in Matrix Metalloproteinases and Inflammatory Components as Prognostic Factors for the Progression of Osteoarthritis

Autorzy:

DOI: 10.3389/fphar.2021.643605
Date: 2021-04-28

CB2 agonism controls pain and subchondral bone degeneration induced by mono-iodoacetate: Implications GPCR functional bias and tolerance development.

Autorzy:

DOI: 10.1016/j.biopha.2021.111283
Date: 2021-01-19

Zobacz także